February 12, 2021
Property investment firm and designer DivcoWest has revealed the complementing of a 480,000-square-foot life scientific researches residential property at the 43-acre Cambridge Crossing mixed-use area at the intersection of the cities of Boston, Cambridge as well as Somerville.
Situated at 250 Water St., biopharmaceutical company Bristol Myers Squibb has actually preleased 360,000 square feet at the structure, which is slated to be finished in the first quarter of 2022.
Cambridge Crossing is slated to be composed of 2 million square feet of laboratory and also workplace, 2.4 million square feet of household space and 100,000 square feet of retail area. The task is connected to two stops on the MBTA Environment-friendly Line. Extra life scientific researches customers at Cambridge Crossing are prepared to consist of Sanofi and Cerevel Therapeutics.
For remarks, concerns or concerns, please call David Cohen